The α7 nicotinic acetylcholine receptor agonist, A-582941, regulates GSK3β and tau phosphorylation:: Potential for disease modification in Alzheimer's disease

被引：0
|
作者：
Nikkel, A. L. [1 ]
Markosyan, S. [1 ]
Martino, B. [1 ]
Gubbins, E. [1 ]
Li, J. [1 ]
Han, E. K. [1 ]
Luo, Y. [1 ]
Hu, M. [1 ]
Puttfarcken, P. [1 ]
Decker, M. [1 ]
Gopalakrishnan, M. [1 ]
Bitner, R. S. [1 ]
机构：
[1] Abbott Labs, Global Pharmaceut Res & Dev, Abbott Pk, IL 60064 USA
来源：
BIOCHEMICAL PHARMACOLOGY | 2007年 / 74卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：SMA28 / SMA29
页数：2
相关论文
共 50 条
  • [31] Genetic Variation in the α7 Nicotinic Acetylcholine Receptor is Associated with Delusional Symptoms in Alzheimer’s Disease
    Robyn Carson
    David Craig
    Dominic Hart
    Stephen Todd
    Bernadette McGuinness
    Janet A. Johnston
    Francis A. O’Neill
    Craig W. Ritchie
    A. Peter Passmore
    NeuroMolecular Medicine, 2008, 10 : 377 - 384
  • [32] Alzheimer's disease is associated with a selective increase in α7 nicotinic acetylcholine receptor immunoreactivity in astrocytes
    Teaktong, T
    Graham, A
    Court, J
    Perry, R
    Jaros, E
    Johnson, M
    Hall, R
    Perry, E
    GLIA, 2003, 41 (02) : 207 - 211
  • [33] Increased alpha 7 nicotinic acetylcholine receptor protein levels in Alzheimer's disease patients
    Chu, L
    Lam, K
    Ma, E
    Chan, M
    Lee, D
    GERONTOLOGIST, 2004, 44 : 257 - 258
  • [34] Selective α7 nicotinic acetylcholine receptor activation regulates glycogen synthase kinase3β and decreases tau phosphorylation in vivo
    Bitner, Robert S.
    Nikkel, Arthur L.
    Markosyan, Stella
    Otte, Stephani
    Puttfarcken, Pamela
    Gopalakrishnan, Murali
    BRAIN RESEARCH, 2009, 1265 : 65 - 74
  • [35] Role of the nicotinic acetylcholine receptor in Alzheimer's disease pathology and treatment
    Lombardo, Sylvia
    Maskos, Uwe
    NEUROPHARMACOLOGY, 2015, 96 : 255 - 262
  • [36] Cortical α7 Nicotinic Acetylcholine Receptor and β-Amyloid Levels in Early Alzheimer Disease
    Ikonomovic, Milos D.
    Wecker, Lynn
    Abrahamson, Eric E.
    Wuu, Joanne
    Counts, Scott E.
    Ginsberg, Stephen D.
    Mufson, Elliott J.
    DeKosky, Steven T.
    ARCHIVES OF NEUROLOGY, 2009, 66 (05) : 646 - 651
  • [37] GSK3 signaling regulates BACE1 expression and APP processing and its pharmaceutical potential for Alzheimer's disease
    Song, W.
    Ly, P.
    Wu, Y.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 17 - 17
  • [38] Glycogen synthase kinase 3 (GSK3) inhibition: a potential therapeutic strategy for Alzheimer's disease
    Karati, Dipanjan
    Meur, Shreyasi
    Roy, Souvik
    Mukherjee, Swarupananda
    Debnath, Biplab
    Jha, Sajal Kumar
    Sarkar, Biresh Kumar
    Naskar, Saheli
    Ghosh, Priya
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, : 2319 - 2342
  • [39] Haplotype analysis of α7 nicotinic acetylcholine receptor gene (CHRNA7) and associations with Alzheimer's disease
    Carson, R
    McIlroy, SP
    Passmore, AP
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2005, 138B (01) : 41 - 41
  • [40] GSK3 and p53 - is there a link in Alzheimer's disease?
    Carole J Proctor
    Douglas A Gray
    Molecular Neurodegeneration, 5
12345